APA (7th ed.) Citation

A, G., Z, K., SW, T., D, P., IP, K., W, X., . . . P, C. (2024). Blocking Oncostatin M receptor abrogates STAT3 mediated integrin signaling and overcomes chemoresistance in ovarian cancer. NPJ precision oncology, 8(1), 127. https://doi.org/10.1038/s41698-024-00593-y

Chicago Style (17th ed.) Citation

A, Geethadevi, et al. "Blocking Oncostatin M Receptor Abrogates STAT3 Mediated Integrin Signaling and Overcomes Chemoresistance in Ovarian Cancer." NPJ Precision Oncology 8, no. 1 (2024): 127. https://doi.org/10.1038/s41698-024-00593-y.

MLA (9th ed.) Citation

A, Geethadevi, et al. "Blocking Oncostatin M Receptor Abrogates STAT3 Mediated Integrin Signaling and Overcomes Chemoresistance in Ovarian Cancer." NPJ Precision Oncology, vol. 8, no. 1, 2024, p. 127, https://doi.org/10.1038/s41698-024-00593-y.